TOKYO -- Japanese pharmaceutical company Shionogi will sign a licensing agreement this month aimed at mass-producing a proposed coronavirus test that provides faster results without requiring special equipment or technicians, the company announced on Monday.
The test was developed by Nihon University professor Masayasu Kuwahara and his team. If it proves effective, Shionogi will seek approval from Japan's health ministry, hoping to commercialize the test this fall.
